Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1992 May 30;304(6839):1426–1429. doi: 10.1136/bmj.304.6839.1426

Testicular cancer and related neoplasms.

G M Mead 1
PMCID: PMC1882209  PMID: 1628023

Full text

PDF
1426

Images in this article

1426FIG 1
on p.1426
1427FIG 2
on p.1427
1428FIG 3
on p.1428
1428FIG 4
on p.1428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dearnaley D. P., A'Hern R. P., Whittaker S., Bloom H. J. Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962-1987. Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):773–781. doi: 10.1016/0360-3016(90)90396-2. [DOI] [PubMed] [Google Scholar]
  2. Dearnaley D. P., Horwich A., A'Hern R., Nicholls J., Jay G., Hendry W. F., Peckham M. J. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer. 1991;27(6):684–691. doi: 10.1016/0277-5379(91)90166-b. [DOI] [PubMed] [Google Scholar]
  3. Einhorn L. H., Williams S. D., Loehrer P. J., Birch R., Drasga R., Omura G., Greco F. A. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol. 1989 Mar;7(3):387–391. doi: 10.1200/JCO.1989.7.3.387. [DOI] [PubMed] [Google Scholar]
  4. Fosså S. D., Aass N., Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):383–388. doi: 10.1016/0360-3016(89)90334-9. [DOI] [PubMed] [Google Scholar]
  5. Freedman L. S., Parkinson M. C., Jones W. G., Oliver R. T., Peckham M. J., Read G., Newlands E. S., Williams C. J. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987 Aug 8;2(8554):294–298. doi: 10.1016/s0140-6736(87)90889-0. [DOI] [PubMed] [Google Scholar]
  6. Gershenson D. M., Morris M., Cangir A., Kavanagh J. J., Stringer C. A., Edwards C. L., Silva E. G., Wharton J. T. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990 Apr;8(4):715–720. doi: 10.1200/JCO.1990.8.4.715. [DOI] [PubMed] [Google Scholar]
  7. Gregory C., Peckham M. J. Results of radiotherapy for stage II testicular seminoma. Radiother Oncol. 1986 Aug;6(4):285–292. doi: 10.1016/s0167-8140(86)80195-5. [DOI] [PubMed] [Google Scholar]
  8. Horwich A., Dearnaley D. P., Duchesne G. M., Williams M., Brada M., Peckham M. J. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol. 1989 Aug;7(8):1150–1156. doi: 10.1200/JCO.1989.7.8.1150. [DOI] [PubMed] [Google Scholar]
  9. Horwich A., Dearnaley D. P., Nicholls J., Jay G., Mason M., Harland S., Peckham M. J., Hendry W. F. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol. 1991 Jan;9(1):62–69. doi: 10.1200/JCO.1991.9.1.62. [DOI] [PubMed] [Google Scholar]
  10. Jansen R. L., Sylvester R., Sleyfer D. T., ten Bokkel Huinink W. W., Kaye S. B., Jones W. G., Keizer J., van Oosterom A. T., Meyer S., Vendrik C. P. Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group) Eur J Cancer. 1991;27(6):695–698. doi: 10.1016/0277-5379(91)90168-d. [DOI] [PubMed] [Google Scholar]
  11. Lewis C. R., Fossà S. D., Mead G., ten Bokkel Huinink W., Harding M. J., Mill L., Paul J., Jones W. G., Rodenburg C. J., Cantwell B. BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours. Ann Oncol. 1991 Mar;2(3):203–211. doi: 10.1093/oxfordjournals.annonc.a057906. [DOI] [PubMed] [Google Scholar]
  12. Loehrer P. J., Sr, Williams S. D., Einhorn L. H. Testicular cancer: the quest continues. J Natl Cancer Inst. 1988 Nov 2;80(17):1373–1382. doi: 10.1093/jnci/80.17.1373. [DOI] [PubMed] [Google Scholar]
  13. McKendrick J. J., Theaker J., Mead G. M. Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer. 1991 Feb 1;67(3):684–689. doi: 10.1002/1097-0142(19910201)67:3<684::aid-cncr2820670326>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  14. Mead G. M., Stenning S. P., Parkinson M. C., Horwich A., Fossa S. D., Wilkinson P. M., Kaye S. B., Newlands E. S., Cook P. A. The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol. 1992 Jan;10(1):85–94. doi: 10.1200/JCO.1992.10.1.85. [DOI] [PubMed] [Google Scholar]
  15. Nichols C. R., Roth B. J., Heerema N., Griep J., Tricot G. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med. 1990 May 17;322(20):1425–1429. doi: 10.1056/NEJM199005173222004. [DOI] [PubMed] [Google Scholar]
  16. Nichols C. R., Saxman S., Williams S. D., Loehrer P. J., Miller M. E., Wright C., Einhorn L. H. Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience. Cancer. 1990 Apr 1;65(7):1641–1646. doi: 10.1002/1097-0142(19900401)65:7<1641::aid-cncr2820650731>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  17. Nichols C. R., Tricot G., Williams S. D., van Besien K., Loehrer P. J., Roth B. J., Akard L., Hoffman R., Goulet R., Wolff S. N. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol. 1989 Jul;7(7):932–939. doi: 10.1200/JCO.1989.7.7.932. [DOI] [PubMed] [Google Scholar]
  18. Nichols C. R., Williams S. D., Loehrer P. J., Greco F. A., Crawford E. D., Weetlaufer J., Miller M. E., Bartolucci A., Schacter L., Einhorn L. H. Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol. 1991 Jul;9(7):1163–1172. doi: 10.1200/JCO.1991.9.7.1163. [DOI] [PubMed] [Google Scholar]
  19. Reinberg Y., Manivel J. C., Fraley E. E. Carcinoma in situ of the testis. J Urol. 1989 Aug;142(2 Pt 1):243–247. doi: 10.1016/s0022-5347(17)38720-7. [DOI] [PubMed] [Google Scholar]
  20. Roth B. J., Greist A., Kubilis P. S., Williams S. D., Einhorn L. H. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol. 1988 Aug;6(8):1239–1247. doi: 10.1200/JCO.1988.6.8.1239. [DOI] [PubMed] [Google Scholar]
  21. Senturia Y. D. The epidemiology of testicular cancer. Br J Urol. 1987 Oct;60(4):285–291. doi: 10.1111/j.1464-410x.1987.tb04970.x. [DOI] [PubMed] [Google Scholar]
  22. Smith D. B., Newlands E. S., Begent R. H., Rustin G. J., Bagshawe K. D. Optimum management of pineal germ cell tumours. Clin Oncol (R Coll Radiol) 1991 Mar;3(2):96–99. doi: 10.1016/s0936-6555(05)81173-2. [DOI] [PubMed] [Google Scholar]
  23. von der Maase H., Rørth M., Walbom-Jørgensen S., Sørensen B. L., Christophersen I. S., Hald T., Jacobsen G. K., Berthelsen J. G., Skakkebaek N. E. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986 Nov 29;293(6559):1398–1401. doi: 10.1136/bmj.293.6559.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES